L589-1975 Screening compound: N~4~-{2-[benzyl(methyl)amino]ethyl}-1-[(5-methoxy-1-methyl-1H-indol-3-yl)methyl]-4-piperidinecarboxamide

L589-1975 Screening compound: N~4~-{2-[benzyl(methyl)amino]ethyl}-1-[(5-methoxy-1-methyl-1H-indol-3-yl)methyl]-4-piperidinecarboxamide
L589-1975 Screening compound: N~4~-{2-[benzyl(methyl)amino]ethyl}-1-[(5-methoxy-1-methyl-1H-indol-3-yl)methyl]-4-piperidinecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L589-1975
N~4~-{2-[benzyl(methyl)amino]ethyl}-1-[(5-methoxy-1-methyl-1H-indol-3-yl)methyl]-4-piperidinecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L589-1975

Molecular Formula

C27H36N4O2 (C27 H36 N4 O2)

Compound Name

N~4~-{2-[benzyl(methyl)amino]ethyl}-1-[(5-methoxy-1-methyl-1H-indol-3-yl)methyl]-4-piperidinecarboxamide

IUPAC name

N-{2-[benzyl(methyl)amino]ethyl}-1-[(5-methoxy-1-methyl-1H-indol-3-yl)methyl]piperidine-4-carboxamide

SMILES

CN(CCNC(C1CCN(Cc2cn(C)c(cc3)c2cc3OC)CC1)=O)Cc1ccccc1

InChI

InChI=1S/C27H36N4O2/c1-29(18-21-7-5-4-6-8-21)16-13-28-27(32)22-11-14-31(15-12-22)20-23-19-30(2)26-10-9-24(33-3)17-25(23)26/h4-10,17,19,22H,11-16,18,20H2,1-3H3,(H,28,32)

InChI Key

DKEJMTLOFBELIF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27464210

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

448.61

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

2.982

Distribution Coefficient, logD

-1.745

Water Solubility, LogSw

-3.16

Polar Surface Area

42.423

Acid Dissociation Constant (pKa)

13.35

Base Dissociation Constant (pKb)

12.13

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

44.44

L589-1975 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

GPCR Targeted Library (31838 compounds)

Indole Derivatives (10091 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

PD-1/L1 Library (498 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
Targets:
  • GPCR
  • Others
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with L589-1975 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L589-1975?
Check Price and Availability of L589-1975, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L589-1975 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L589-1975
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L589-1975
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L589-1975 available by request